Financial Services

CorVel Corporation (CRVL)

$2.9B
Market Cap
28.2
P/E Ratio
1.05
Beta
Dividend Yield
Piotroski 7/9Beneish M -2.75 Clean

Quantitative Summary

Deterministic

CRVL trades at 28.2x earnings — a 47% premium to its sector average of 19.2x — without a dominant ROIC-WACC spread. Strong operational fundamentals (Piotroski 7/9).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of CorVel Corporation demonstrate robust capital efficiency, evidenced by a return on invested capital (ROIC) of 27.9%, which suggests the firm generates substantial value relative to its cost of equity. This high ROIC is underpinned by strong profitability metrics, specifically net and gross margins of 10.6% and 23.4% respectively, while revenue expansion tracks at a 12.6% year-over-year pace. Qualitative indicators further reinforce financial stability; a Piotroski F-Score of 7/9 signals healthy balance sheet strength and earnings quality, whereas the Beneish M-Score of -2.75 indicates management actions are unlikely to be manipulating reported results. Collectively, these metrics paint a picture of an operation with durable competitive advantages and transparent financial reporting within the Financial Services sector.

Valuation analysis reveals a notable divergence between current market pricing and intrinsic value estimates derived from discounted cash flow modeling. The stock currently trades at 28.2x forward earnings, significantly exceeding the sector average multiple of 17.8x, which implies the market is pricing in aggressive growth expectations or premium quality factors not fully reflected in peer valuations. However, this elevated entry point contrasts sharply with a DCF-derived fair value estimate of $20 per share; without knowing the current price to calculate an exact discount or premium percentage, the gap between the implied intrinsic value and the multiple expansion suggests potential overvaluation if consensus growth assumptions fail to materialize. Investors must weigh whether the 12.6% revenue trajectory justifies such a steep valuation differential compared to historical norms and sector peers.

While specific risk factor deltas, insider activity data, or Fama-French alpha metrics were not provided in this dataset, the existing profile presents a classic high-multiple growth scenario where downside protection relies heavily on sustaining top-line momentum. The combination of superior profitability and low earnings manipulation risk offers structural resilience, yet the wide gap between current multiples and sector averages introduces sensitivity to any deceleration in revenue growth or margin compression.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$25$18$15
3%$29$20$16
4%$35$23$17

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $20 (+0.0%). Not investment advice.

Valuation Context

28.2x
CRVL P/E
19.2x
Sector Avg
+47%
vs Sector

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
-2.75
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

23.4%
Gross Margin
10.6%
Net Margin
27.9%
ROIC
+12.6%
Revenue Growth (YoY)
+24.8%
Earnings Growth (YoY)
91.6M
Free Cash Flow

Balance Sheet Health

0.70x
Debt / Equity
1.90x
Current Ratio
-1.0x
Net Debt / EBITDA
150.4M
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $0.14
Act: $0.13
-5.8%
Q3
✗ Miss
Est: $0.16
Act: $0.13
-17.5%
Q2
✗ Miss
Est: $0.16
Act: $0.12
-21.8%
Q1
✗ Miss
Est: $0.14
Act: $0.11
-21.8%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

Forward P/E
-0.11
PEG Ratio
7.83
Price/Book
259180
Avg Volume
$117.22
52W High
$44.83
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$53M
Tracked Passive Exposure
8
ETFs Holding CRVL
0.06%
Avg Weight in ETFs
$93B
Total ETF AUM

When investors buy or sell ETFs like XHS or VFQY, the fund manager is mechanically forced to buy or sell CRVL shares regardless of CorVel Corporation's individual fundamentals. We estimate $53M of passive capital is structurally linked to CRVL through 8 tracked ETFs. Passive flows have a limited but growing influence on CRVL's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in CorVel Corporation to visualize passive redemption contagion across ETFs and collateral stocks.

CRVL Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
CRVLEpicenterVBKETFVHTETFSPSMETFBTSGLow RiskMOHLow RiskHUMLow RiskCLOVUnknownCNCMed Risk
CRVL Price Drop (%)0

If CorVel Corporation (CRVL) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies BRIGHTSPRING HEALTH SERVICES (BTSG) as the most exposed collateral stock, sharing 3 ETFs with CRVL. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 8 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

CRVL Ownership Dynamics

Ticker
CRVL

Float lock-up computed from 8 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

CRVL Capital Efficiency

How efficiently does CorVel Corporation convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$92M
EBITDA
$150M
FCF Conversion
61%
Reinvestment Rate
39%
61% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

CorVel Corporation converts 61% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-04-162$55.96$111.92
2026-04-141$54.30$54.3
2026-04-139,016$52.77$475,774.32
2026-04-108,342$54.14$451,635.88
2026-03-2486$54.20$4,661.2
2026-02-263$50.72$152.16
2026-02-244$49.82$199.28
2026-02-206$48.21$289.26
2026-02-1946$48.42$2,227.32
2026-02-17189$49.20$9,298.8
2026-02-13113$47.27$5,341.51
2026-02-0544$49.08$2,159.52
2026-01-231$71.05$71.05
2026-01-1458$68.41$3,967.78
2026-01-0962$72.00$4,464
2026-01-05147$65.74$9,663.78
2026-01-021$67.67$67.67
2025-12-191$70.24$70.24
2025-12-151$69.93$69.93

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare CRVL to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.